Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

By leveraging genetic variants linked to 25(OH)D levels as IVs, we aim to determine whether genetically predicted 25(OH)D concentrations influence the likelihood of developing either allergic or nonallergic asthma.

Source: 1. Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Exploring the causal relationship between 25-hydroxyvitamin D and asthma: A bidirectional Mendelian randomization study

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Exploring the causal relationship between 25-hydroxyvitamin D and asthma: A bidirectional Mendelian randomization study

Genetic instrumental-variable study · Medicine · 2025

Original publication title

Exploring the causal relationship between 25-hydroxyvitamin D and asthma: A bidirectional Mendelian randomization study

Xiaosheng Wu; Xueqin Zhan; Chao Ouyang

Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The role of 25-hydroxyvitamin D (25(OH)D) in disease has attracted much attention. However current research findings on the relationship between 25(OH)D and asthma are not completely consistent. This study aims to explore the potential causal relationship between 25(OH)D levels and asthma using a bidirectional Mendelian randomization (MR) approach. Data from large genome-wide association studies related to the study phenotypes were utilized. Genetic correlation data for 25(OH)D were obtained from the European Bioinformatics Institute database, and genetic correlation data for asthma risk were sourced from the FinnGen biobank.

A 2-sample MR analysis was conducted, primarily using the inverse-variance weighted method to assess the impact of 25(OH)D levels on asthma. Sensitivity analyses and horizontal pleiotropy tests were performed to ensure the reliability of the results. Additionally, a reverse MR analysis was conducted to explore potential reverse causal relationships. The MR analysis indicated no significant causal relationship between 25(OH)D levels and allergic asthma (odds ratio [OR] = 1.13, 95% CI: 0.91 to 1.40, P = .259) or nonallergic asthma (OR = 1.06, 95% CI: 0.89 to 1.28, P = .501).

Furthermore, the reverse MR analysis did not reveal a significant impact of asthma on 25(OH)D levels (allergic asthma: OR = 1.01, 95% CI: 0.99 to 1.02, P = .363; nonallergic asthma: OR = 1.03, 95% CI: 0.98 to 1.07, P = .235). The consistency of results across sensitivity analyses and various statistical methods supports this conclusion. Evidence from bidirectional MR suggests no causal relationship between 25(OH)D levels and either allergic or nonallergic asthma.

Authors’ abstract

The role of 25-hydroxyvitamin D (25(OH)D) in disease has attracted much attention. However current research findings on the relationship between 25(OH)D and asthma are not completely consistent. This study aims to explore the potential causal relationship between 25(OH)D levels and asthma using a bidirectional Mendelian randomization (MR) approach. Data from large genome-wide association studies related to the study phenotypes were utilized. Genetic correlation data for 25(OH)D were obtained from the European Bioinformatics Institute database, and genetic correlation data for asthma risk were sourced from the FinnGen biobank.

A 2-sample MR analysis was conducted, primarily using the inverse-variance weighted method to assess the impact of 25(OH)D levels on asthma. Sensitivity analyses and horizontal pleiotropy tests were performed to ensure the reliability of the results. Additionally, a reverse MR analysis was conducted to explore potential reverse causal relationships. The MR analysis indicated no significant causal relationship between 25(OH)D levels and allergic asthma (odds ratio [OR] = 1.13, 95% CI: 0.91 to 1.40, P = .259) or nonallergic asthma (OR = 1.06, 95% CI: 0.89 to 1.28, P = .501).

Furthermore, the reverse MR analysis did not reveal a significant impact of asthma on 25(OH)D levels (allergic asthma: OR = 1.01, 95% CI: 0.99 to 1.02, P = .363; nonallergic asthma: OR = 1.03, 95% CI: 0.98 to 1.07, P = .235). The consistency of results across sensitivity analyses and various statistical methods supports this conclusion. Evidence from bidirectional MR suggests no causal relationship between 25(OH)D levels and either allergic or nonallergic asthma.

Publication and source details

Original title: Exploring the causal relationship between 25-hydroxyvitamin D and asthma: A bidirectional Mendelian randomization study

Xiaosheng Wu; Xueqin Zhan; Chao Ouyang

Medicine · 2025

* Correspondence: Xiaosheng Wu, Department of Respiratory and Critical Care Medicine, Nanchang People’s Hospital, Nanchang 330006, Jiangxi Province, PR China (e-mail: 47310438@qq.com).Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:12:58.355213+00:00

DOI: 10.1097/md.0000000000044249 · PMC12401316